Amber Therapeutics
Amber Therapeutics is developing an intelligent implantable closed-loop neurostimulation therapy for people suffering from urinary incontinence.
- What
- Health Tech
- When
- Jan 2021
- CEO
- Aidan Crawley
- Status
- Private
- Investment
- Active
- OSE Board Director
- Liliane Chamas